Pharmaceuticals
Pharmaceuticals encompass the research, development and manufacturing of drugs for disease treatment and prevention by applying chemistry, pharmacology and medical science. Effective medications and therapies are critical to enhancing patient health outcomes. These medications continue to improve based on growing knowledge of biochemical processes and drug interactions.
Top Stories
-
Feature
14 Nov 2024
Employing ML to boost pharmacokinetics in drug development
Machine learning revolutionizes pharmacokinetics by accurately predicting drug behavior and optimizing dosages, streamlining drug development and regulatory approval. Continue Reading
-
Podcast
13 Nov 2024
Exploring gaps in GLP-1 research, care and coverage
Dr. Lydia Alexander discusses progress in obesity management and identifies gaps in GLP-1 research, care delivery and insurance coverage on 'Healthcare Strategies.' Continue Reading
-
Podcast
13 Nov 2024
Exploring gaps in GLP-1 research, care and coverage
Dr. Lydia Alexander discusses progress in obesity management and identifies gaps in GLP-1 research, care delivery and insurance coverage on 'Healthcare Strategies.' Continue Reading
-
Feature
30 Oct 2024
Role of advanced modeling and virtual data in drug approvals
Advanced modeling and virtual data help biopharma companies design efficient, ethical and cost-effective trials to accelerate drug development and regulatory approvals. Continue Reading
-
Feature
21 Oct 2024
Understanding PMBs' role and impact on drug pricing
PBMs shape drug pricing and healthcare costs, but growing market consolidation sparks concerns about less competition, higher prices and fewer options for patients. Continue Reading
-
News
18 Oct 2024
Hurricane Helene triggers dialysis and IV fluid shortage
Following Hurricane Helene, damages to a manufacturing plant in North Carolina and subsequent nationwide IV fluid shortages have forced manufacturers to mobilize global networks. Continue Reading
-
News
17 Oct 2024
Medicare drug price negotiations impact non-chain pharmacies
Although Medicare drug price negotiations intend to expand medication access, independent pharmacies are facing challenges associated with reimbursement and PBM strategies. Continue Reading
-
Feature
15 Oct 2024
Climate change drives drug demand for chronic conditions
As climate change intensifies, the pharmaceutical industry faces a new challenge: rising drug demand for climate-sensitive chronic conditions amid more frequent extreme weather events. Continue Reading
-
News
10 Oct 2024
PBMs call for FTC commissioners' recusal from antitrust case
Cigna, UnitedHealth and CVS Caremark are requesting FTC commissioners step down from a PBM lawsuit, alleging prejudgment and bias in the agency's review process. Continue Reading
-
Feature
07 Oct 2024
Are compounded GLP-1 drugs safe?
Growing demand for GLP-1 weight loss drugs has caused market shortages, prompting compounding pharmacies to offer alternatives that raise safety and reliability issues. Continue Reading
-
Feature
03 Oct 2024
Exploring injectable allergy medicines as the season extends
Epinephrine, corticosteroids, monoclonal antibodies and allergy immunotherapies are injectable allergy medicines that can offer severe allergy relief as seasons are prolonged. Continue Reading
-
News
24 Sep 2024
FDA approves self-administered nasal influenza vaccine
By the 2025-2026 respiratory virus season, FluMist, the nasal influenza vaccine, will be available for home vaccination via self- or caregiver-administration to eligible patients. Continue Reading
-
News
23 Sep 2024
FTC sues PBMs, affiliated GPOs for inflating insulin prices
Caremark Rx, Express Scripts, and OptumRx are facing legal repercussions after the FTC accused them of insulin price inflation in a lawsuit announced on Sept. 20, 2024. Continue Reading
-
News
18 Sep 2024
GLP-1 drugs for primary prevention of cardiovascular disease
According to a study from Dandelion Health, an estimated 44 million people in the U.S. could benefit from using GLP-1 drugs for the primary prevention of cardiovascular disease. Continue Reading
-
News
09 Sep 2024
AMA reports low PBM competition, high vertical integration
A 2024 AMA annual report confirms low competition and high vertical integration in PBM markets, urging regulatory action to protect patients and ensure affordability. Continue Reading
-
News
04 Sep 2024
Study uncovers risks of buying semaglutide online
The rise of unregulated online sales of semaglutide poses serious health risks, emphasizing the need for professional guidance and stricter regulation. Continue Reading
-
News
29 Aug 2024
FDA clears automatic insulin pump for type 2 diabetes
Automated insulin pumps have previously been available only for type 1 diabetes. However, the FDA recently cleared the Insulet SmartAdjust, the first automatic insulin pump for type 2 diabetes. Continue Reading
-
News
28 Aug 2024
Eli Lilly's single-dose Zepbound vials expand obesity care
Eli Lilly introduced single-dose vials of Zepbound (tirzepatide) to offer flexible dosing, cost savings and improved obesity care through its Lilly Direct service. Continue Reading
-
News
27 Aug 2024
FDA approves updated mRNA COVID-19 vaccines
The updated Moderna, Pfizer-BioNTech, Spikevax, and Comirnaty mRNA COVID-19 vaccines, also called the 2024-2025 formulations, should protect against recently circulating strains. Continue Reading
-
Feature
19 Aug 2024
Formulating a specialty drug management playbook using expert insights
Using this playbook, healthcare organizations can better navigate the complexities of specialty drug management to optimize care, control costs, and improve patient outcomes. Continue Reading
-
News
15 Aug 2024
CMS reaches agreements for lower prices of 10 drugs
The negotiated prices mark a 38–79% discount off of list prices that could save roughly $6 billion annually. Continue Reading
-
Feature
12 Aug 2024
Exploring trends shaping the future of specialty pharmacy
The pharmacy industry is evolving with specialty drugs, requiring advanced management and technology solutions to control costs and improve patient outcomes. Continue Reading
-
News
09 Aug 2024
40% of Americans say pediatric vaccinations are extremely important
Data from a Gallup poll revealed that fewer Americans regard childhood vaccinations as important or extremely important. Continue Reading
-
Answer
07 Aug 2024
Understanding the widespread impacts of pharmacy deserts
Pharmacy deserts, perpetuated by multiple factors, have significant implications for patient care and public health. Continue Reading
-
News
01 Aug 2024
Vizient estimates a 3.81% inflation in drug prices in 2025
Vizient's summer 2024 Pharmacy Market Outlook predicts a drug inflation rate of 3.81% in 2025. Continue Reading
-
News
26 Jul 2024
Boar's head recalls 200K pounds of deli meat due to Listeria risk
Boar's Head recalls 200,000 pounds of deli meat over potential Listeria contamination linked to a multi-state outbreak. Continue Reading
-
News
25 Jul 2024
FTC interim report reveals PBMs' role in rising drug costs
An FTC interim report exposes how pharmacy benefit managers (PBMs) inflate drug prices, significantly impacting healthcare costs. Continue Reading
-
Feature
15 Jul 2024
Understanding the role of 4D printing in the healthcare industry
Adding to the evolution of 3D printing, 4D printing provides an additional tool for enhancing healthcare outcomes. Continue Reading
-
News
26 Jun 2024
Klas reports on pharmacy purchasing optimization analytics solutions
The report looked at various digital solutions for pharmacy purchasing optimization analytics solutions, assessing customer satisfaction with vendors. Continue Reading
-
News
25 Jun 2024
Teva launches authorized generic of Victoza in the US
Teva launches authorized generic of Victoza (liraglutide) in the United States, potentially reducing costs, improving access, and enhancing diabetes care outcomes. Continue Reading
-
Feature
17 Jun 2024
2023 USP Report highlights economic factors driving drug shortages
The USP's 2023 report links drug shortages to economic factors, urging policy reforms, pricing adjustments, and supply chain diversification. Continue Reading
-
News
14 Jun 2024
Only 1% of ACA Marketplace plans cover GLP-1 drugs for obesity
Although up to 82% of plans cover GLP-1 medications for diabetes, 1% or less cover GLP-1 drugs for obesity, such as Saxenda, Wegovy, and Zepbound. Continue Reading
-
News
11 Jun 2024
Combined COVID-19/influenza vaccine is superior to individual vaccines
Moderna’s mRNA-1083 vaccine combines the company’s seasonal influenza candidate and next-generation COVID-19 vaccines for improved immune response. Continue Reading
-
Feature
10 Jun 2024
Understanding the differences between 503A, 503B compounding pharmacies
Compounding pharmacies customize medications for patients, with 503A serving individual prescriptions and 503B producing larger batches for healthcare facilities. Continue Reading
-
News
04 Jun 2024
NIH-developed AI tool predicts patients’ response to immunotherapy
Using routine clinical data, NIH researchers have developed an AI tool to predict immunotherapy responses. Continue Reading
-
News
31 May 2024
Ro launches GLP-1 tracker to help patients navigate GLP-1 shortages
To address the GLP-1 medication shortage, Ro launched the GLP-1 Supply Tracker to provide patients with real-time insights and alerts on drug availability. Continue Reading
-
Answer
13 May 2024
Defining vaccine hesitancy, understanding how to address it
Hilary Hatch, PhD, explores the different aspects of vaccine hesitancy and offers solutions for addressing ongoing issues. Continue Reading
-
News
08 May 2024
Healthcare Realty Trust, KKR forge medical outpatient JV
Healthcare Realty Trust and KKR team up in a strategic joint venture to bolster medical outpatient facilities, enhancing care accessibility and quality. Continue Reading
-
News
01 May 2024
FDA takes actions to ensure the safety, effectiveness of LDTs
The FDA highlighted actions it’s taking to address ongoing concerns about the safety and efficacy of LDTs, which are becoming increasingly popular healthcare tools. Continue Reading
-
Feature
30 Apr 2024
Exploring the top 20 biopharma companies Q1 2024 market cap growths
Of the top 20 biopharmaceutical companies to see a profitable Q1 in 2024, Lilly leads with a 33.7% increase, with Nordisk in second, outperforming Johnson & Johnson. Continue Reading
-
Answer
29 Apr 2024
Omnicell launches XT Amplify, amending pharmacy care delivery model
The program offers several features that address ongoing challenges the company’s clients have identified in the current pharmacy care delivery model. Continue Reading
-
News
24 Apr 2024
NIH researchers develop AI tool for personalized oncology
A proof-of-concept study showed that the tool could analyze single-cell RNA sequencing to help match patients to the appropriate cancer drug. Continue Reading
-
Feature
23 Apr 2024
Discovering 6 applications of bioinformatics in drug repurposing
Bioinformatics plays a critical role across pharmaceutical innovation, with many applications in drug discovery and repurposing. Continue Reading
-
News
17 Apr 2024
CRN launches new labeling guidelines for melatonin supplements
Following a surge in melatonin-associated pediatric emergency department visits, the CRN is launching new labeling guidelines. Continue Reading
-
Feature
09 Apr 2024
Understanding the environmental impact of the pharmaceutical industry
Though vital for global health, the pharmaceutical industry's significant environmental impact warrants attention. Continue Reading
-
Feature
08 Apr 2024
Strategies for engaging, managing KOLs in the pharma industry
Pharmaceutical companies must accurately identify KOLs and develop specific engagement and management strategies to gather the valuable insights they can offer. Continue Reading
-
News
04 Apr 2024
Drawbridge Health's NanoDrop gains FDA clearance for at-home blood sampling
Drawbridge Health's FDA-cleared NanoDrop blood sampling lancet device offers convenient, painless, at-home blood testing. Continue Reading
-
News
29 Mar 2024
FDA approves $4.25 million gene therapy for MLD
After receiving FDA approval earlier this month, Orchard Therapeutics plans to price its new MLD gene therapy at $4.25 million. Continue Reading
-
Feature
18 Mar 2024
Exploring Transparency-Rx’s pharmacy benefit manager partners
This article explores "transparent" partners: SmithRx, Liviniti, AffirmedRx, RxPreferred, Navitus Health Solutions, Pharmacy Benefit Dimensions, Salvus, and MedOne. Continue Reading
-
News
15 Mar 2024
Eli Lilly partners with Amazon Pharmacy to deliver GLP-1 drugs
The partnership is helping support the company’s LillyDirect platform, which will now deliver drugs through Amazon or Truepill. Continue Reading
-
News
05 Mar 2024
Over-the-Counter Birth Control Will Be $20 Per Monthly Supply
Perrigo announced that Opill, a hormonal birth control pill recently approved for OTC sale, will be priced at approximately $20 per month. Continue Reading
-
Answer
04 Mar 2024
Developing Quality Assurance Standards for Biologics, Biosimilars
Despite long-standing standards for small-molecule drugs, quality assurance guidelines for biologics and biosimilars are less robust and comprehensive. Continue Reading
-
Feature
28 Feb 2024
Continuous Manufacturing Revolutionizes Pharmaceutical Production
Continuous manufacturing transforms pharmaceutical production, enhancing efficiency and supply chain resilience. Continue Reading
-
News
28 Feb 2024
Amgen Opens Its Most Advanced Manufacturing Site in Central Ohio
On February 26, Amgen announced the opening of its most advanced manufacturing site located in New Albany, Ohio. Continue Reading
-
News
27 Feb 2024
Pediatric Antidepressant Prescription Rates Increased 66%
A study in Pediatrics revealed that adolescent, teen, and young adult antidepressant prescription rates increased by 66% between January 2016 and December 2022. Continue Reading
-
Feature
26 Feb 2024
Understanding Digital Health Passports in a Post-Pandemic World
In the digital post-pandemic world, digital health passports may be a critical public health tool for minimizing disease spread and contact tracing. Continue Reading
-
Feature
20 Feb 2024
Advancing Packaging Technologies for Climate-Adaptive Supply Chains
Advancing packaging tech for climate-adaptive pharma supply chains is crucial to protect product integrity, ensure patient safety, and minimize environmental impact. Continue Reading
-
Feature
14 Feb 2024
Senate Report Exposes Big Pharma's Profiteering at Americans’ Expense
US Senate HELP Committee's 2024 report exposes J&J, Merck, and BMS for prioritizing profits over Americans' well-being with exorbitant drug prices. Continue Reading
-
News
12 Feb 2024
Senate Hearing Challenges Pharma CEOs on Drug Pricing
On February 8th, CEOs from Bristol Myers Squibb, Johnson & Johnson, and Merck were grilled by US senators about high prescription drug prices. Continue Reading
-
Feature
07 Feb 2024
Advancing Sterility Assurance Through Environmental Monitoring
Environmental monitoring ensures pharmaceutical product safety by detecting and controlling contamination risks and maintaining quality standards. Continue Reading
-
News
02 Feb 2024
Breaking Down the Cost of Sickle Cell Disease Gene Therapies
As CMS attempts to navigate the astronomical costs of new sickle cell disease treatments, including gene therapy, it is critical to break down treatment costs. Continue Reading
-
Answer
29 Jan 2024
Exploring Gene and Cell Therapy Integration in Pharmacies
Integrating gene and cell therapy in pharmacies ensures accessibility, personalized care, and effective management, enhancing patient outcomes. Continue Reading
-
News
25 Jan 2024
Healthcare Workers Urge Health Systems to Address Climate Change
A survey from the Commonwealth Fund revealed that approximately 80% of clinicians believe their hospitals should be working to address climate change and its climate impact. Continue Reading
-
Answer
23 Jan 2024
Exploring and Managing GLP-1 Receptor Agonists in Weight Loss
As GLP-1 drugs like semaglutide become increasingly popular for weight loss, providers must optimize the tools and strategies they use to manage the medications. Continue Reading
-
Feature
22 Jan 2024
A Pulse Check on Advancements in the Life Sciences, Pharma Industry
A pulse check on the life sciences and pharmaceutical industry advancements highlights breakthroughs in gene therapy, targeted oncology, and male contraception. Continue Reading
-
News
17 Jan 2024
Mayo Clinic Launches Weight Loss Prescription Program
Mayo Clinic is establishing the Mayo Clinic Diet Medical Weight Loss Rx Program to help patients on weight loss drugs manage symptoms and enforce other lifestyle changes. Continue Reading
-
Answer
09 Jan 2024
How the Medical Education System Contributes to Physician Burnout
PharmaNewsIntelligence sits down with Arti Masturzo to discuss multiple components of the medical education system and how these factors contribute to burnout. Continue Reading
-
News
05 Jan 2024
Lilly Launches Digital Obesity, Migraine, Diabetes Management Platform
Eli Lilly and Company is launching LillyDirect, a digital healthcare platform used to manage obesity, migraine, and diabetes for patients in the US. Continue Reading
-
News
03 Jan 2024
500 Drugs from Over 140 Brands Are Expected to Cost More This Year
Reuters broke the news that the approximately 500 drugs in the US are supposed to increase in January 2024. Continue Reading
-
Feature
02 Jan 2024
Understanding the Pharmacotherapy of Hypertensive Disorders
Understanding how to manage hypertensive disorders can help providers address the growing number of patients with hypertension and hypertension-related complications. Continue Reading
-
Feature
28 Dec 2023
Navigating the Complex Terrain of Influenza Vaccine Strain Selection
Effective influenza strain selection and vaccine production ensure seasonal vaccines align with virus evolution, enhancing prevention and global health outcomes. Continue Reading
-
Feature
26 Dec 2023
Understanding Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
SNRIs play a critical role in managing psychiatric and pain disorders, with comparable effects to SSRIs. Continue Reading
-
News
20 Dec 2023
Novo Nordisk Launches Vaccine Initiative for Airborne Infections
Novo Nordisk announced it would allocate $260 million to research and vaccine development initiatives focused on airborne viruses. Continue Reading
-
News
15 Dec 2023
Researcher Study Non-Opioid Pain Medication for Diabetic Neuropathy
Vertex Pharmaceuticals announced phase 2 study results on VX-548, a drug to manage pain in patients with diabetic peripheral neuropathy. Continue Reading
-
Answer
12 Dec 2023
Exploring Data Analytics in Pharmaceutical Marketing
PharmaNewsIntelligence explores the role of data analytics in pharmaceutical marketing. Continue Reading
-
Answer
05 Dec 2023
Optimizing Cancer Care Pathways Through Precision Medicine, RWD
Real-world data and precision medicine can optimize cancer care for patients by understanding and combating complications while speeding up effective treatment options. Continue Reading
-
Feature
04 Dec 2023
Exploring Prescription Discount Cards’ Role in Medication Adherence
Prescription discount cards offer savings to patients without adequate insurance coverage, improving medication adherence. Continue Reading
-
Answer
20 Nov 2023
Exploring Pharmacy Benefit Manager Reforms: Transparency
PharmaNewsIntelligence explores the current PBM landscape and how transparency reform differs from current industry standards. Continue Reading
-
News
09 Nov 2023
Sage Therapeutics Announces Wholesale Cost of Zuranolone, $15,900
In a recent press release, the company noted that the wholesale acquisition cost for a 14-day treatment cycle will be $15,900. Continue Reading
-
Feature
08 Nov 2023
8 Steps to Negotiating Successful Pharmaceutical Partnerships
Strategic pharmaceutical partnerships enable groundbreaking innovations and improve healthcare delivery. Continue Reading
-
Feature
07 Nov 2023
Are Therapeutic Advancements Impacting the Demand for Surgery?
The growing rate of innovative therapeutics and noninvasive alternatives may reduce the demand for surgery across the United States. Continue Reading
-
News
06 Nov 2023
Psychiatrists Prescribe or Recommend Ozempic, Other Weight Loss Drugs
Responses from 13 mental health departments at significant health systems suggest that nearly half of psychiatrists are prescribing or recommending Ozempic. Continue Reading
-
Feature
01 Nov 2023
Understanding the Dangers of Nutraceuticals and Dietary Supplements
Although these compounds are marketed as health products, a lack of regulation complicates patient safety and comprehensive research on the formulations. Continue Reading
-
News
31 Oct 2023
Pharmacy Workforce Conditions Drive 3-Day CVS, Walgreens Staff Walkout
CVS and Walgreens pharmacy staff started a walkout on Monday to protest unsuitable working conditions. Continue Reading
-
Feature
31 Oct 2023
Innovative Tech for Drug Manufacturing: Revolutionizing Pharma
Innovative pharmaceutical technology for drug manufacturing enhances drug quality, efficiency, and customization. Continue Reading
-
News
27 Oct 2023
Pfizer, BioNTech Reveals Data on Combined COVID and Flu Vaccine
The companies state that results from phase 1 and 2 clinical trials reflect promising outcomes for a combined vaccine. Continue Reading
-
Feature
25 Oct 2023
Exploring Business Development Strategies for Pharma Startups
Exploring business development strategies for pharmaceutical startups is vital for innovation, patient care, economic growth, and global health challenges. Continue Reading
-
Answer
24 Oct 2023
Evaluating the Breast Cancer Therapeutics Market
An analyst at Citeline provided PharmaNewsIntelligence with insights into current trends, gaps, and predictions in the breast cancer therapeutics market. Continue Reading
-
Feature
17 Oct 2023
Ensuring Drug Safety Through Regulatory Compliance
Regulatory compliance ensures drug safety by enforcing standards, preventing harm, and ensuring quality control. Continue Reading
-
News
13 Oct 2023
Antifungal Therapeutic Drug Monitoring Are Rates Lower Than Use Rates
A recent survey of infectious disease specialists found that antifungal TDM rates are lower than recommended by the IDSA. Continue Reading
-
Feature
09 Oct 2023
10 Things to Know About the Updated 2023 COVID-19 Vaccines
Public awareness of the updated COVID-19, RSV, and flu vaccines is vital for informed decisions and protection against new strains. Continue Reading
-
News
09 Oct 2023
Controlling Oncology Costs with Cross-Benefit Drug Management
In the ever-changing oncology landscape, cross-benefit drug management tackles challenges, reduces costs, and shapes the future of care. Continue Reading
-
Answer
02 Oct 2023
The Importance of Accurately Measuring the Value of New Medications
NPLB noted that including factors, such as diminishing returns and dynamic pricing, helps assess medication value better than traditional CEA. Continue Reading
-
News
02 Oct 2023
Transforming Specialty and Oncology Prior Authorizations
Optum's Specialty Fusion enables a 60% auto-approval rate within 10 minutes, significantly streamlining specialty and oncology authorizations. Continue Reading
-
News
29 Sep 2023
Developing a Sustainable Pharmaceutical Workforce and Workplace
A collaborative report from the APhA, ASHP, and NABP provides strategies for improving pharmacy workplace conditions for a sustainable workforce. Continue Reading
-
Answer
25 Sep 2023
How Can Pharmaceutical Companies Meet Drug Launch Expectations
Deloitte analysts assess market data to understand why many pharmaceutical companies miss expectations during drug launches. Continue Reading
-
News
25 Sep 2023
Escaping the Specialty Drug Tunnel with Cross-Benefit Strategies
Embracing cross-benefit strategies in specialty drug management enhances cost control and quality care and breaks free from the specialty drug tunnel. Continue Reading
-
Feature
20 Sep 2023
How Do Various Stakeholders Define Clinically Meaningful Data?
Understanding how stakeholders define clinically meaningful data can help researchers and investors determine the best pharmaceutical interventions. Continue Reading
-
Feature
19 Sep 2023
Can Pharmaceutical Companies Ethically Sponsor Medical Education?
Although pharmaceutical companies sponsor multiple aspects of medical education, these relationships present a moral gray area. Continue Reading
-
Feature
14 Sep 2023
Expanding Product Portfolios Through Technology Integration
Expanding product portfolios through technology integration streamlines diagnostics, telemedicine, and patient care, revolutionizing healthcare processes. Continue Reading
-
News
06 Sep 2023
How New Platforms Are Saving Patients $4 Billion on Prescription Drugs
Visory Health’s prescription discount cards have contributed over $4 billion in prescription drug savings for over 3 million patients. Continue Reading
-
Feature
05 Sep 2023
7 Ways to Increase Pharmaceutical Sustainability
Enhancing pharmaceutical sustainability safeguards the planet's health while ensuring a vital global supply of medications. Continue Reading